fibrinolytic therapy

Related by string. * fibrinolytics : fibrinolytic systems . acting fibrinolytic . fibrinolytic / THERAPY . Therapy : stem cell therapy . Hormone Replacement Therapy . active antiretroviral therapy . cognitive behavioral therapy . gene therapy . Intensity Modulated Radiation Therapy . therapy . chemo therapy . Chemo Therapy . occupational therapy . radiotherapy radiosurgery proton therapy * *

Related by context. All words. (Click for frequent words.) 74 primary percutaneous coronary 72 tenecteplase 72 thrombolytic therapy 72 reperfusion therapy 71 acute STEMI 71 alteplase 70 fibrinolysis 70 UA NSTEMI 69 STEMI patients 69 unfractionated heparin 69 perioperatively 69 oral anticoagulation 69 percutaneous intervention 69 thrombolysis 69 postprocedure 69 Percutaneous Coronary Intervention 68 eptifibatide 68 rt PA 68 revascularization procedures 68 thrombolytics 68 angioplasty stenting 68 reinfarction 68 IOP lowering 67 infarction STEMI 67 sirolimus eluting stents 67 clot dissolving drug 67 certolizumab 67 LMWH 67 elective PCI 67 revascularisation 67 intra arterial 67 paclitaxel eluting stents 67 revascularization procedure 67 rFVIIa 67 chemoradiation therapy 67 colorectal liver metastases 67 hepatic metastases 66 coronary intervention 66 tirofiban 66 intracoronary 66 postintervention 66 rtPA 66 antiarrhythmic drug 66 systemic corticosteroids 66 nicardipine 66 antithrombotic therapy 66 calcineurin inhibitor 66 anticoagulant therapy 66 ICD implantation 66 surgical revascularization 66 abciximab 66 β blocker 66 bolus dose 66 neoadjuvant therapy 66 preoperative chemotherapy 66 chemoembolization 66 clot busting therapy 66 concurrent chemoradiation 66 revascularization 66 antiarrhythmic drugs 66 glycoprotein IIb IIIa inhibitors 66 FOLFOX4 65 antimicrobial prophylaxis 65 periprocedural 65 conventional angiography 65 asystole 65 argatroban 65 stable angina 65 Thrombolysis 65 NSTE ACS 65 postoperative morbidity 65 fondaparinux 65 electrical cardioversion 65 unfractionated heparin UFH 65 dexmedetomidine 65 cystoscopic 65 anticoagulation 65 coronary revascularization 65 glycoprotein IIb IIIa inhibitor 65 lipid lowering therapy 65 concomitant AEDs 65 OPCAB 65 abacavir lamivudine 65 concomitant antibiotics 65 thienopyridine 65 left ventricular dysfunction 65 sinus rhythm 65 DES implantation 65 reperfusion 65 ST elevation myocardial 65 cerebral angiography 65 fibrinolytic 65 eplerenone 65 octreotide LAR 65 radical nephrectomy 65 thromboembolic events 65 mitomycin C 65 carotid artery blockage 65 fulvestrant 65 intravenous tPA 65 transthoracic 65 paroxysmal AF 65 thromboprophylaxis 64 stenoses 64 cystectomy 64 everolimus eluting stents 64 pamidronate 64 unstable angina UA 64 radiotherapy RT 64 β blockers 64 aldosterone antagonist 64 bypass grafting 64 intravesical 64 ARB telmisartan 64 TAXUS Express Stent 64 antibiotic prophylaxis 64 antiplatelet drugs 64 NATRECOR ® 64 drug eluting stent implantation 64 warfarin therapy 64 NSTEMI 64 saline placebo 64 AGILECT R 64 refractory ischemia 64 stent implantation 64 chlorambucil 64 thrombus aspiration 64 nephrectomy 64 infarct size 64 inotropic 64 insulin detemir 64 angiographic restenosis 64 nonischemic 64 DAPT 64 ximelagatran 64 patients undergoing CABG 64 TURBT 64 intravenous bolus 64 occlusive disease 64 recanalization 64 GP IIb IIIa inhibitors 64 DVT prophylaxis 64 antiplatelet medications 64 invasive coronary angiography 64 extubated 64 aspirin clopidogrel 64 beta blocker therapy 64 NATRECOR R 64 ATACAND 64 liver resection 64 divalproex sodium 64 nebulization 64 postoperative bleeding 64 venography 64 severe exacerbations 64 hepatectomy 64 coronary angiography 64 endarterectomy 64 dobutamine 64 GnRH agonist 64 APTIVUS r 64 arteriography 64 irbesartan 64 mycophenolate mofetil 64 saphenous vein grafts 64 intravenous bisphosphonates 64 thrombolytic agents 63 tumor resection 63 ICD shocks 63 aldosterone antagonists 63 multivessel disease 63 patients undergoing percutaneous 63 recurrent ischemia 63 glomerular filtration 63 olmesartan 63 tissue plasminogen activator tPA 63 Doxil ® 63 systemic hypotension 63 debulking surgery 63 extubation 63 iodixanol 63 unstable angina pectoris 63 adjuvant radiotherapy 63 bezafibrate 63 otamixaban 63 KRAS mutant tumors 63 thrombocytopenic 63 percutaneous coronary interventions 63 GP IIb IIIa inhibitor 63 mg clopidogrel 63 antiplatelet medication 63 nephron sparing surgery 63 paricalcitol 63 ß blockers 63 thrombotic complications 63 ULORIC 63 androgen deprivation 63 pulmonary artery banding 63 upper gastrointestinal bleeding 63 chemoradiotherapy 63 intravenous diuretics 63 CsA 63 dalteparin 63 postoperative chemotherapy 63 ARIXTRA 63 anticoagulated 63 methotrexate monotherapy 63 cytoreductive surgery 63 NMIBC 63 intravenous tissue plasminogen 63 pulmonary artery catheterization 63 external beam radiotherapy 63 levosimendan 63 IIIa inhibitor 63 locoregional 63 oncologic outcomes 63 pneumonectomy 63 ICD therapy 63 atrioventricular block 63 CHOP chemotherapy 63 oral rivaroxaban 63 VTE prophylaxis 63 CorVue ™ 63 clopidogrel Plavix 63 revascularizations 63 Abciximab 63 systemic corticosteroid 63 TNF antagonist 63 undergoing coronary angiography 63 TEVAR 63 lung resection 63 Raptiva r 63 inotropic agents 63 carotid endarterectomy CEA 63 IFN beta 63 adrenalectomy 63 neoadjuvant chemotherapy 63 trabeculectomy 63 cilostazol 63 recurrent glioblastoma multiforme 63 subconjunctival injection 63 mRCC 63 postoperative complication 63 repeat revascularization 63 peginterferon 63 IV bolus 62 percutaneous coronary intervention 62 atorvastatin #mg 62 postoperative AF 62 clot dissolving drugs 62 eculizumab therapy 62 colon resection 62 IFN alfa 62 weekly subcutaneous injections 62 anticoagulation therapy 62 myocardial reperfusion 62 oral anticoagulant therapy 62 XIENCE V PROMUS Stent 62 transurethral resection 62 interferon ribavirin 62 acute myocardial infarction AMI 62 underwent angiography 62 deferoxamine 62 noninferior 62 decompressive surgery 62 APTIVUS ritonavir 62 immunosuppressive regimen 62 vinorelbine 62 BENICAR HCT 62 drotrecogin alfa activated 62 aspirin heparin 62 intravenous cyclophosphamide 62 paracentesis 62 colectomy 62 dose atorvastatin 62 titrated glipizide 62 cardiopulmonary bypass CPB 62 endotracheal intubation 62 catheter angiography 62 ribavirin RBV 62 palliation 62 curative resection 62 recombinant tissue plasminogen 62 pegaptanib 62 immunomodulatory therapy 62 zolmitriptan 62 intravenous IV infusion 62 placebo dexamethasone 62 chemoradiation 62 5-fluorouracil/leucovorin 62 decompensated heart failure 62 occluded artery 62 droperidol 62 carotid endarterectomy 62 rebleeding 62 Vimpat R 62 thoracoscopic lobectomy 62 5FU 62 percutaneous drainage 62 clot busting medications 62 XELOX 62 salmeterol fluticasone 62 ischemia driven 62 virological response 62 ZYVOX 62 dose escalation phase 62 activator tPA 62 PSA nadir 62 crossclamp 62 cannulation 62 serum phosphorous 62 nonoperative 62 low dose Iluvien 62 CANCIDAS 62 IV tPA 62 CR nPR 62 tamsulosin 62 LV dysfunction 62 mg kg dose 62 conventional coronary angiography 62 Coronary Artery Bypass Graft 62 undergoing percutaneous coronary 62 VIRAMUNE 62 radioiodine therapy 62 carotid artery stenting 62 ticlopidine 62 randomized blinded 62 hepatorenal syndrome 62 nonmetastatic prostate cancer 62 octreotide 62 perioperative complications 62 NIHSS score 62 neostigmine 62 anticoagulant warfarin 62 remifentanil 62 perioperative mortality 62 verapamil 62 rosuvastatin #mg 62 clopidogrel pretreatment 62 mycophenolic acid 61 relapsed MM 61 IABP 61 COREG 61 thromboembolic 61 macrolide antibiotic 61 lymph node dissection 61 inotropic therapy 61 coronary artery bypass grafts 61 reintervention 61 NNT = 61 RVOT 61 MACCE 61 nonoperative treatment 61 spiral computed tomography 61 vasopressor 61 idraparinux 61 oral corticosteroids 61 milrinone 61 carotid artery stenosis 61 hypotensive 61 streptokinase 61 resynchronization therapy 61 achieved CCyR 61 MitraClip device 61 resectable 61 cangrelor 61 HBeAg seroconversion 61 antiangiogenic therapy 61 hepatic resection 61 coronary interventions 61 TMP SMX 61 nonobstructive CAD 61 diameter stenosis 61 lymphadenectomy 61 PRADAXA 61 penetrating keratoplasty 61 bolus injection 61 revascularized 61 clot busters 61 hemodynamically stable 61 thromboembolic complications 61 thiazide diuretic 61 CIMZIA ™ 61 Elitek 61 FROVA 61 platelet inhibition 61 pegylated interferon alfa 2b 61 KRAS mutations occur 61 LNG IUS 61 clot busting medication 61 coronary artery stenosis 61 guanfacine 61 epoprostenol 61 HoLEP 61 idarubicin 61 clomipramine 61 ketorolac 61 achieved ACR# 61 analgesic medications 61 somatostatin analog 61 allogeneic stem cell 61 EBRT 61 prespecified secondary 61 aortic insufficiency 61 solifenacin 61 tinzaparin 61 HSCT 61 MDCT angiography 61 Perforomist Inhalation Solution 61 oral antidiabetic medication 61 BoNTA 61 dual antiplatelet therapy 61 underwent resection 61 tolvaptan 61 reteplase 61 DMARD 61 INTEGRILIN R 61 symptomatic VTE 61 noninvasive outpatient 61 reoperations 61 decitabine 61 adjuvant radiation 61 prospectively defined 61 oblimersen 61 pharmacologic stress 61 biochemical recurrence 61 TNF inhibitor 61 postoperative radiotherapy 61 circulating EPCs 61 radical cystectomy 61 lanreotide 61 prospectively stratified 61 ALND 61 undergone splenectomy 61 polypectomy 61 trans urethral resection 61 Radical prostatectomy 61 cerebral perfusion 61 paroxysmal atrial fibrillation 61 corticosteroid therapy 61 bovine thrombin 61 tolterodine ER 61 pelvic lymphadenectomy 61 thoracoscopy 61 AV fistulas 61 parathyroidectomy 61 dose dexamethasone 61 interferon alfa 2b 61 nelfinavir 61 icatibant 61 ACTEMRA TM 61 caspofungin 61 CABG surgery 61 BYSTOLIC 61 nesiritide 61 esomeprazole 61 Lenalidomide 61 symptomatic carotid stenosis 61 recurrent GBM 61 epirubicin 61 ZOLINZA 61 diagnostic angiography 61 intraoperative complications 61 oral moxifloxacin 61 sipuleucel T 61 CRRT 61 carotid revascularization 61 underwent percutaneous coronary 61 riociguat 61 systolic function 61 vecuronium 61 Fludara 61 calcineurin inhibitors 61 4mg/kg 61 Carotid endarterectomy 61 NovoSeven ® 60 percutaneous transluminal coronary angioplasty 60 acute coronary syndromes 60 TAVR 60 morphometric vertebral fractures 60 CABG surgeries 60 symptomatic hyponatremia 60 colorectal cancer liver metastases 60 PASI scores 60 continuous intravenous infusion 60 anagrelide 60 Taxus Stent 60 ablative therapy 60 intravenous morphine 60 glycated hemoglobin levels 60 neoadjuvant 60 Zevalin consolidation 60 myocardial revascularization 60 antihypertensive therapy 60 biochemical relapse 60 complete cytogenetic response 60 EGFR TKIs 60 dosage regimens 60 invasive aspergillosis 60 prophylactic cranial irradiation 60 artery stenosis 60 timepoints 60 calcium antagonist 60 EXJADE 60 transarterial 60 acute coronary syndromes ACS 60 cisplatin chemotherapy 60 Enhanced External Counterpulsation 60 bivalirudin 60 amisulpride 60 #beta estradiol 60 ribavirin therapy 60 Postoperative 60 gemtuzumab ozogamicin 60 stented 60 renal dysfunction 60 fluvastatin 60 mild renal insufficiency 60 LVSD 60 hepatic function 60 DOXIL 60 angiographic outcomes 60 wedge resection 60 VT VF 60 warfarin anticoagulation 60 postsurgical 60 tiotropium 60 enhanced external counterpulsation 60 arterial revascularization 60 ropivacaine 60 Percutaneous coronary intervention 60 posttransplant 60 SCIg 60 #mg QD [002] 60 Adjuvant chemotherapy 60 platelet inhibitor 60 tolterodine 60 acetazolamide 60 inotropes 60 Cardiopulmonary bypass 60 STEMIs 60 TACE 60 immunosuppressive agents 60 bronchodilation 60 carotid stents 60 virologic breakthrough 60 silent ischemia 60 liver transplant recipients 60 calcified plaques 60 definite stent thrombosis 60 somatostatin analogues 60 lispro 60 CK MB 60 elective percutaneous coronary 60 QRS duration 60 transesophageal echocardiography 60 azacitidine 60 hypofractionated radiation 60 postoperative pulmonary 60 ritonavir boosted lopinavir 60 clopidogrel 60 mCRC patients 60 surrogate endpoint 60 undergoing CABG 60 rHuEPO 60 genotypic resistance 60 echocardiographic 60 myocardial ischemia 60 Cypher Stent 60 VELCADE melphalan 60 nephrectomies 60 Dabigatran 60 MYCAMINE 60 darunavir ritonavir 60 #mg/day [002] 60 angiographically 60 NAVISTAR R 60 anti androgen 60 transcatheter aortic valve implantation 60 sleeve lobectomy 60 #mg dose [003] 60 urate lowering therapy 60 coronary revascularisation 60 docetaxel prednisone 60 esophagectomy 60 sotalol 60 antiplatelet therapy 60 GnRH agonists 60 VAPRISOL 60 elevated transaminases 60 EDARBI 60 NIHSS 60 LVEF 60 INVEGA ® 60 metastatic RCC 60 DaTscan 60 metastatic neuroendocrine tumors 60 lung metastases 60 Lamictal XR 60 locoregional disease 60 cerebrovascular events 60 antimuscarinic 60 Kaplan Meier analysis 60 tamoxifen Nolvadex ® 60 lenalidomide dexamethasone 60 pacemaker implantation 60 VIIBRYD 60 symptomatic paroxysmal AF 60 CYPHER Stent 60 QTc prolongation 60 atazanavir ritonavir 60 biologic DMARD 60 enoxaparin 60 intravenous thrombolysis 60 micafungin 60 intravesical therapy 60 occluded catheters 60 X ray angiography 60 contrast induced nephropathy 60 biliary tract cancer 60 ALT flares 60 pump CABG 60 coronary stenosis 60 locoregional recurrence 60 cardiogenic shock 60 adverse cytogenetics 60 ischemic cardiomyopathy 60 clevidipine 60 STEMI 60 biventricular pacing 60 INTEGRILIN 60 nondiabetic patients 60 moderate renal impairment 60 levetiracetam 60 intracerebral hemorrhage 60 MIRAPEX 60 Gliadel Wafer 60 lobectomy 60 Hypotension 60 pegylated alpha interferon 60 glucocorticoid therapy 60 galiximab 60 TAXUS Stent 60 haematologic 60 full thickness plication 60 corticosteroid dose 60 Dabigatran etexilate 60 mesalazine 60 coronary revascularization procedures 60 thrombolytic agent 60 Tasigna prolongs 60 percutaneous ablation 60 tipranavir ritonavir 60 postoperative infections 60 desvenlafaxine succinate 60 anticlotting drugs 60 peginterferon alfa 60 renal tumors 60 CIMZIA TM 60 malperfusion 60 pyridostigmine 60 angiotensin II receptor blockers 60 adult chronic ITP 60 Postoperative complications 60 preintervention 60 flutamide 60 LHRH agonists 60 REOPRO 60 intrathecal chemotherapy 60 coadministration 60 arteriovenous fistula 60 #mg dose [001] 60 chemotherapeutic regimen 60 Surgical resection 60 5-FU/LV 60 pancreatic resection 60 laparotomy 60 operable breast cancer 60 arterial grafts 60 antithrombotic 60 voriconazole 60 azacytidine 60 amphotericin B 60 Postoperatively 60 detectable HCV RNA 60 treprostinil 60 renal insufficiency 60 neointimal hyperplasia 60 neoadjuvant treatment 59 intracranial hemorrhage ICH 59 lipid lowering agents 59 deep venous thromboses 59 intravitreal injections 59 rituximab Rituxan ® 59 intraperitoneal chemotherapy 59 suboptimal echocardiograms 59 clodronate 59 pT3 59 epoetin alfa 59 binary restenosis 59 Known hypersensitivity 59 patients undergoing noncardiac 59 mesalamine granules 59 chlorthalidone 59 angina pectoris 59 cinacalcet 59 advanced adenomas 59 lipid lowering drugs 59 achieve sustained virologic 59 AA Amyloidosis 59 angiotensin converting enzyme inhibitors 59 infarction NSTEMI 59 pentoxifylline 59 stage IIIB 59 dacarbazine 59 HBeAg positive patients 59 STEMI undergoing 59 hip resurfacing arthroplasty 59 transfemoral 59 Desferal 59 Adjunctive 59 FOLFIRI 59 fludarabine cyclophosphamide 59 Stent thrombosis 59 PREZISTA r 59 serum urate 59 erlotinib Tarceva ® 59 dyspnoea 59 LVRS 59 tricuspid regurgitation 59 undergo percutaneous coronary 59 methylprednisolone 59 lamotrigine 59 hemodynamically significant 59 ACE inhibitor 59 ureteroscopy 59 histrelin 59 sirolimus eluting 59 duplex ultrasonography 59 vWD 59 antiplatelet 59 PRADAXA #mg 59 stratifying patients 59 oxcarbazepine 59 pegylated interferon alfa 59 Free Survival PFS 59 flecainide 59 RLAI 59 dose clopidogrel 59 noncardiac 59 angiotensin converting enzyme inhibitor 59 infusional 59 secondary efficacy endpoint 59 ACE inhibitors beta blockers 59 invasive angiography 59 Flu Cy 59 dose titration 59 hematologic toxicity 59 undetectable HBV DNA 59 vandetanib 59 virologic failure 59 parecoxib 59 PSADT 59 non valvular atrial 59 TAXUS Liberté stent 59 PLX STROKE targeting 59 prostate carcinoma 59 smoldering multiple myeloma 59 antithrombotic therapies 59 concomitant medications 59 vessel occlusion 59 cystoid macular edema 59 segmentectomy 59 systemic immunosuppressive 59 splenectomized patients 59 thrombectomy 59 Octreolin 59 serum phosphorus 59 ritonavir boosted 59 TAXOTERE R 59 LCP Tacro ™ 59 Secondary endpoints included 59 intermittent hemodialysis 59 sinus tachycardia 59 FRAGMIN R 59 asymptomatic carotid stenosis 59 pancreatectomy 59 antiretroviral naive 59 coronary angiogram 59 herpetic keratitis 59 pCR 59 intravitreal triamcinolone 59 antirheumatic 59 NPH insulin 59 SLNB 59 MSCT 59 Mitomycin C 59 tamponade 59 sirolimus 59 aspirin beta blockers 59 BEXXAR Therapeutic Regimen 59 carotid artery stenting CAS 59 vaginal hysterectomy 59 Percutaneous Coronary Interventions 59 ASCT 59 neutropenic patients 59 RRMS patients 59 zoledronic acid 59 underwent CABG 59 Losartan 59 noncardiac surgery 59 catheterisation 59 antihypertensive agents 59 sirolimus stent 59 segment elevation myocardial 59 retroperitoneal 59 pericardial effusion 59 defibrillator implant 59 STEMI ST 59 coronary stenoses 59 chest radiographs 59 overt nephropathy 59 overlapping toxicities 59 thienopyridines 59 atherosclerotic renal artery stenosis 59 cytoreduction 59 ventricular tachycardia VT 59 gadobutrol 59 LTRA 59 cytoreductive nephrectomy 59 systolic dysfunction 59 LATUDA 59 tele ICU 59 EDSS scores 59 undergoing coronary artery 59 LPV r 59 amoxicillin clavulanate 59 PSVT 59 XIENCE V stent 59 SYNTAX trial 59 portal vein thrombosis 59 TNF alpha inhibitor 59 intracerebral haemorrhage 59 post thrombotic syndrome 59 GIK infusion 59 inhaled iloprost 59 nadroparin 59 MYLOTARG 59 deferasirox 59 teriflunomide 59 NAbs 59 androgen ablation 59 zotarolimus 59 intracardiac 59 renal denervation 59 antithymocyte globulin 59 coronary stenting 59 pramipexole 59 Decitabine 59 venous thromboembolism VTE prophylaxis 59 lacosamide 59 Carotid stenting 59 ProstaScint 59 atrial ablation 59 triamcinolone 59 labetalol 59 stage IIIb IV 59 AZOR 59 Acute Ischemic Stroke 59 primidone 59 left ventricular systolic 59 nephrotoxicity 59 interferon beta therapy 59 opioid analgesia 59 ejection fractions 59 postoperative atrial fibrillation 59 FOLFIRI alone 59 Ranolazine 59 alpha blocker 59 Pioglitazone 59 myeloablative 59 ischemic lesions 59 aPTT 59 HIPEC 59 Acute renal failure 59 tapentadol ER 59 Coronary artery bypass grafting 59 bioprosthetic valve 59 metformin monotherapy 59 KAPIDEX 59 aprepitant 59 dosing frequency 59 cidofovir 59 mL kg 59 FOLFOX 59 ciclosporin 59 imipenem 59 bypass grafts 59 target vessel revascularization 59 ipsilateral stroke 59 active comparator 59 antiarrhythmic medications 59 post operatively 59 Helicobacter pylori eradication 59 antifibrinolytic 59 adenoidectomy 59 MULTAQ 59 achieved PASI 59 Apidra ® 59 noninferiority 59 anthracycline therapy 59 pain palliation 59 factor Xa 59 nonadherent 59 prostate TURP 59 FDG PET 59 CABG 59 coronary blockages 59 plus dexamethasone 59 goserelin 59 oral hypoglycemic agents 59 EGRIFTA ™ tesamorelin 59 unresectable tumors 59 levodopa carbidopa 59 angiographies 59 prehospital setting 59 symptomatic intracranial 59 CCyR 59 xanthine oxidase inhibitor 59 heparin induced thrombocytopenia 59 myocardial viability 59 dose cytarabine 59 hemodilution 59 R# #mg BID 59 APTIVUS R 59 Target Lesion Revascularization TLR 59 F FDG PET 59 oral olanzapine 59 ventilatory 59 anthracycline containing 59 bi ventricular pacing 59 coronary CTA 59 infective endocarditis 59 sunitinib Sutent 59 lymphocytosis 59 partial nephrectomy 59 adriamycin 59 hypoperfusion 59 postdose 59 PNH patients 59 oral anticoagulants 59 venous thromboembolic disease 59 FAMPYRA 59 severe renal impairment 59 primary aldosteronism 59 inhaled nitric oxide 59 esophagogastric 59 chemotherapy docetaxel 59 antiepileptic medications 59 hemodynamically 59 transarterial chemoembolization 59 transurethral 59 Intracoronary 59 CYPHER R Sirolimus eluting 59 MabCampath 59 8mg/kg 59 mg QD 59 percutaneous biopsy 59 acute aortic dissection 59 FOLFOX6 59 coronary anatomy 59 neurologic progression 59 canakinumab 59 unfavorable cytogenetics 59 bendamustine 59 #mg dose [002] 59 allogeneic HSCT 59 cranial irradiation 59 neuroleptics 59 OADs 59 sternotomy 59 gefitinib Iressa 59 antegrade 59 invasive candidiasis 59 nortriptyline 59 dose cohort 59 PegIFN RBV 59 mg ustekinumab 59 Combination therapy 59 pre operatively 59 hepatic arterial 59 androgen suppression 58 nonresponders 58 pulmonary capillary wedge 58 follicular lymphomas 58 coinfected patients 58 myocardial perfusion 58 autologous SCT 58 cerebral vasospasm

Back to home page